Therapeutic agents effective in preventing HF by affecting one or more of these mechanistic pathways include diuretics, angiotensin‐converting enzyme and angiotensin receptor inhibitors, beta‐adrenergic receptor blockers, mineralocorticoid receptor antagonists, statins, and Na+‐glucose co‐transporter 2 (SGLT2) inhibitors [30, 31, 32, 33, 34, 35, 36]. Here, NR3C2 is linked to hydrops fetalis.